GB0228787D0 - Morpholine dopamine agonists - Google Patents

Morpholine dopamine agonists

Info

Publication number
GB0228787D0
GB0228787D0 GB0228787A GB0228787A GB0228787D0 GB 0228787 D0 GB0228787 D0 GB 0228787D0 GB 0228787 A GB0228787 A GB 0228787A GB 0228787 A GB0228787 A GB 0228787A GB 0228787 D0 GB0228787 D0 GB 0228787D0
Authority
GB
United Kingdom
Prior art keywords
morpholine
dopamine agonists
dopamine
agonists
morpholine dopamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0228787A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0228787A priority Critical patent/GB0228787D0/en
Publication of GB0228787D0 publication Critical patent/GB0228787D0/en
Priority to MXPA05006151A priority patent/MXPA05006151A/en
Priority to DE60331769T priority patent/DE60331769D1/en
Priority to AP2005003325A priority patent/AP2005003325A0/en
Priority to EP03812639A priority patent/EP1572214B1/en
Priority to US10/727,168 priority patent/US7323462B2/en
Priority to PL377480A priority patent/PL377480A1/en
Priority to DK03812639.7T priority patent/DK1572214T3/en
Priority to CNA2007101049354A priority patent/CN101117335A/en
Priority to CNB2003801056771A priority patent/CN100488510C/en
Priority to AT03812639T priority patent/ATE460938T1/en
Priority to ES03812639T priority patent/ES2339767T3/en
Priority to NZ540505A priority patent/NZ540505A/en
Priority to KR1020057010474A priority patent/KR100796102B1/en
Priority to JP2005502342A priority patent/JP3889775B2/en
Priority to CA002508262A priority patent/CA2508262C/en
Priority to YUP-2005/0445A priority patent/RS51442B/en
Priority to OA1200500171A priority patent/OA13014A/en
Priority to SI200331801T priority patent/SI1572214T1/en
Priority to GEAP20038838A priority patent/GEP20074272B/en
Priority to BR0317102-7A priority patent/BR0317102A/en
Priority to PCT/IB2003/005683 priority patent/WO2004052372A1/en
Priority to PT03812639T priority patent/PT1572214E/en
Priority to AU2003302878A priority patent/AU2003302878B2/en
Priority to EA200500801A priority patent/EA009589B1/en
Priority to PE2003001234A priority patent/PE20040906A1/en
Priority to MYPI20034690A priority patent/MY144338A/en
Priority to ARP030104524A priority patent/AR042339A1/en
Priority to TW092134694A priority patent/TW200423944A/en
Priority to GT200300277A priority patent/GT200300277A/en
Priority to HN2003000401A priority patent/HN2003000401A/en
Priority to PA20038591601A priority patent/PA8591601A1/en
Priority to UY28117A priority patent/UY28117A1/en
Priority to NL1024981A priority patent/NL1024983C2/en
Priority to IS7843A priority patent/IS7843A/en
Priority to NO20052557A priority patent/NO330143B1/en
Priority to ZA200504727A priority patent/ZA200504727B/en
Priority to HR20050523A priority patent/HRP20050523A2/en
Priority to TNP2005000159A priority patent/TNSN05159A1/en
Priority to MA28324A priority patent/MA27605A1/en
Priority to CR7869A priority patent/CR7869A/en
Priority to CO05056566A priority patent/CO5700781A2/en
Priority to EC2005005850A priority patent/ECSP055850A/en
Priority to HK06102107.0A priority patent/HK1081850A1/en
Priority to JP2006157609A priority patent/JP3920908B2/en
Priority to US11/425,030 priority patent/US7576081B2/en
Priority to JP2006352505A priority patent/JP4624341B2/en
Priority to US12/496,864 priority patent/US7902188B2/en
Priority to CY20101100367T priority patent/CY1110130T1/en
Ceased legal-status Critical Current

Links

GB0228787A 2002-12-10 2002-12-10 Morpholine dopamine agonists Ceased GB0228787D0 (en)

Priority Applications (49)

Application Number Priority Date Filing Date Title
GB0228787A GB0228787D0 (en) 2002-12-10 2002-12-10 Morpholine dopamine agonists
MXPA05006151A MXPA05006151A (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction.
DE60331769T DE60331769D1 (en) 2002-12-10 2003-12-02 STEN IN THE TREATMENT OF U.A. SEXUAL DYSFUNCTION
AP2005003325A AP2005003325A0 (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
EP03812639A EP1572214B1 (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
US10/727,168 US7323462B2 (en) 2002-12-10 2003-12-02 Morpholine dopamine agonists
PL377480A PL377480A1 (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
DK03812639.7T DK1572214T3 (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
CNA2007101049354A CN101117335A (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
CNB2003801056771A CN100488510C (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
AT03812639T ATE460938T1 (en) 2002-12-10 2003-12-02 MORPHOLINE DERIVATIVES FOR USE AS DOPAMINE AGONISTS IN THE TREATMENT OF, AMONG OTHERS. SEXUAL DYSFUNCTION
ES03812639T ES2339767T3 (en) 2002-12-10 2003-12-02 MORFOLINE DERIVATIVES FOR USE AS DOPAMINE AGONISTS IN THE TREATMENT OF SEXUAL DYSFUNCTION BETWEEN OTHERS.
NZ540505A NZ540505A (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
KR1020057010474A KR100796102B1 (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
JP2005502342A JP3889775B2 (en) 2002-12-10 2003-12-02 I. A. Morpholine derivatives for use as dopamine agonists in the treatment of sexual dysfunction
CA002508262A CA2508262C (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
YUP-2005/0445A RS51442B (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
OA1200500171A OA13014A (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a sexual dysfunction.
SI200331801T SI1572214T1 (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
GEAP20038838A GEP20074272B (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
BR0317102-7A BR0317102A (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of sexual dysfunction i.a
PCT/IB2003/005683 WO2004052372A1 (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
PT03812639T PT1572214E (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
AU2003302878A AU2003302878B2 (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopamine agonists in the treatment of I.a. sexual dysfunction
EA200500801A EA009589B1 (en) 2002-12-10 2003-12-02 Morpholine derivatives for use as dopanine agonists in the treatment of a sexual dysfunction
PE2003001234A PE20040906A1 (en) 2002-12-10 2003-12-05 MORPHOLINE DERIVATIVES AS DOPAMINE AGONISTS
MYPI20034690A MY144338A (en) 2002-12-10 2003-12-08 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
ARP030104524A AR042339A1 (en) 2002-12-10 2003-12-09 DOPAMINE MORPHOLINIC AGONISTS
TW092134694A TW200423944A (en) 2002-12-10 2003-12-09 Morpholine dopamine agonists
GT200300277A GT200300277A (en) 2002-12-10 2003-12-09 DOPAMINE MORPHILINIC AGONISTS
HN2003000401A HN2003000401A (en) 2002-12-10 2003-12-09 DOPAMINE MORPHOLINIC AGONISTS
PA20038591601A PA8591601A1 (en) 2002-12-10 2003-12-10 DOPAMINE MORPHOLINIC AGONISTS
UY28117A UY28117A1 (en) 2002-12-10 2003-12-10 DOPAMINE MORPHOLINIC AGONISTS
NL1024981A NL1024983C2 (en) 2002-12-10 2003-12-10 Morphine as dopamine agonists.
IS7843A IS7843A (en) 2002-12-10 2005-05-12 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
NO20052557A NO330143B1 (en) 2002-12-10 2005-05-26 Morpholine derivatives, preparations containing such, such compounds for use as a medicament and the use thereof for the manufacture of medicaments for the treatment of disease
ZA200504727A ZA200504727B (en) 2002-12-10 2005-06-09 Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
HR20050523A HRP20050523A2 (en) 2002-12-10 2005-06-09 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
TNP2005000159A TNSN05159A1 (en) 2002-12-10 2005-06-10 MORPHOLINE DERIVATIVES FOR USE AS AGONISTS OF DOPAMINE IN THE TREATMENT OF SEXUAL DYSFUNCTION
MA28324A MA27605A1 (en) 2002-12-10 2005-06-10 Morpholine derivatives for use as dopamine agonists in the treatment of sexual dysfunction
CR7869A CR7869A (en) 2002-12-10 2005-06-10 DOPAMINE MORPHOLINIC AGONISTS
CO05056566A CO5700781A2 (en) 2002-12-10 2005-06-10 DOPAMINE MORPHOLINIC AGONISTS
EC2005005850A ECSP055850A (en) 2002-12-10 2005-06-10 DOPAMINE MORPHOLINIC AGONISTS
HK06102107.0A HK1081850A1 (en) 2002-12-10 2006-02-17 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
JP2006157609A JP3920908B2 (en) 2002-12-10 2006-06-06 I. A. Morpholine derivatives for use as dopamine agonists in the treatment of sexual dysfunction
US11/425,030 US7576081B2 (en) 2002-12-10 2006-06-19 Morpholine dopamine agonists
JP2006352505A JP4624341B2 (en) 2002-12-10 2006-12-27 I. A. Morpholine derivatives for use as dopamine agonists in the treatment of sexual dysfunction
US12/496,864 US7902188B2 (en) 2002-12-10 2009-07-02 Morpholine dopamine agonists
CY20101100367T CY1110130T1 (en) 2002-12-10 2010-04-26 MORPHOLINE PRODUCTS FOR USE AS DOPAMINE AGONISTS IN THERAPEUTIC DISEASE Therapeutic Treatment I.A.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0228787A GB0228787D0 (en) 2002-12-10 2002-12-10 Morpholine dopamine agonists

Publications (1)

Publication Number Publication Date
GB0228787D0 true GB0228787D0 (en) 2003-01-15

Family

ID=9949423

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0228787A Ceased GB0228787D0 (en) 2002-12-10 2002-12-10 Morpholine dopamine agonists

Country Status (5)

Country Link
CN (2) CN100488510C (en)
GB (1) GB0228787D0 (en)
GT (1) GT200300277A (en)
TN (1) TNSN05159A1 (en)
ZA (1) ZA200504727B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB851311A (en) * 1958-04-02 1960-10-12 Geigy Ag J R Morpholine compounds and their production
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
AU1738900A (en) * 1998-11-19 2000-06-05 Nortran Pharmaceuticals Inc. Serotonin ligands as pro-erectile compounds
FR2791346B3 (en) * 1999-03-25 2001-04-27 Sanofi Sa NOVEL MORPHOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
CN100488510C (en) 2009-05-20
ZA200504727B (en) 2006-06-28
CN1723023A (en) 2006-01-18
TNSN05159A1 (en) 2007-05-14
GT200300277A (en) 2004-08-13
CN101117335A (en) 2008-02-06

Similar Documents

Publication Publication Date Title
IL163928A0 (en) Pyridinoylpiperidines as 5-htf agonists
EG25482A (en) Inhibitors
PL372902A1 (en) New use
PL376920A1 (en) Substituted 4-alkoxyoxazol derivatives as ppar agonists
TWI368482B (en) New 2-pyridinylethylbenzamide derivatives
GB2390700B (en) Narrow/wide cache
AU2003230392A8 (en) Beta-secretase inhibitors
AU2003265689A8 (en) Replacement memory device
GB0228787D0 (en) Morpholine dopamine agonists
GB2390996B (en) Screw holder
GB0313606D0 (en) Morpholine dopamine agonists
GB0308460D0 (en) Morpholine dopamine agonists
GB0326148D0 (en) Morpholine derivatives
GB2409193B (en) Object holder
SI1534667T1 (en) Muscarinic agonists
AU154268S (en) Holder
GB0315440D0 (en) Brakepad holder
GB0309979D0 (en) Deformable-mirror holder
GB0224842D0 (en) Holder
GB0212680D0 (en) Holder
GB0223720D0 (en) New use
GB0218422D0 (en) New use
GB0200737D0 (en) New use
GB0200531D0 (en) New use
GB0203207D0 (en) New use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)